Form 8-K - Current report:
SEC Accession No. 0001437749-25-021276
Filing Date
2025-06-25
Accepted
2025-06-25 17:08:09
Documents
14
Period of Report
2025-06-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K blgo20250624_8k.htm   iXBRL 8-K 63172
2 EXHIBIT 99.1 - PRESS RELEASE ex_834327.htm EX-99.1 7288
  Complete submission text file 0001437749-25-021276.txt   200219

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blgo-20250619.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blgo-20250619_def.xml EX-101.DEF 11056
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blgo-20250619_lab.xml EX-101.LAB 14798
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blgo-20250619_pre.xml EX-101.PRE 11161
16 EXTRACTED XBRL INSTANCE DOCUMENT blgo20250624_8k_htm.xml XML 2722
Mailing Address 14921 CHESTNUT ST. WESTMINSTER CA 92683
Business Address 14921 CHESTNUT ST. WESTMINSTER CA 92683 888 400-2863
BIOLARGO, INC. (Filer) CIK: 0000880242 (see all company filings)

EIN.: 650159115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19709 | Film No.: 251074424
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)